Tenderwize
Zurück zur Suche

Discount Agreements for Vilanterol and Fluticasone Furoate

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 189 days left·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Fluticasonfuroat, ATC R03AK10

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

30 / 100

Risikofaktoren

The open-house model is not subject to public procurement law. Legal remedies are through social courts, not procuremen...

No guaranteed minimum volume or value; the contract is non-exclusive and may be superseded by other rebate contracts.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive rebate agreements for pharmaceuticals containing Vilanterol and Fluticasone furoate (ATC R03AK10)
  • Open-house model (not a competitive procurement)
Vollständige Zusammenfassung anzeigen

Non-exclusive open-house rebate agreement for the active substance Vilanterol and Fluticasone furoate (ATC R03AK10) with AOK Bayern. All eligible pharmaceutical companies can join under identical non-negotiable terms. Contract term from 01.05.2025 to 30.04.2027, with possibility of early termination. The procedure is not a public procurement but a permitted open-house model.

Risiken

The open-house model is not subject to public procurement law. Legal remedies are through social courts, not procuremen...

No guaranteed minimum volume or value; the contract is non-exclusive and may be superseded by other rebate contracts.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

  • Only pharmaceutical companies are eligible as potential contractors.

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Contract and annex must be signed and submitted in paper (two copies) with handwritten signature or electronically with qualified electronic signature.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria – all eligible participants are accepted.

Auftraggeber

Ort

München, DEU

Website

www.aok.de

Auftraggeberprofil

Profil öffnen

Kennung

DE811695320

Tätigkeit

Health

Lose (1)

LOT-0001

Discount Agreements for Vilanterol and Fluticasone Furoate

Open-house model for discount agreements on pharmaceuticals containing Vilanterol and Fluticasone furoate. All interested pharmaceutical companies that meet the eligibility criteria may conclude identical non-exclusive rebate agreements.

SuppliesFrameworkEU fundedElectronic submission

Ort

DE212, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No award criteria – all eligible participants are accepted.

Frist

Deadline Mar 05, 2027

Vergabedetails

Veröffentlichungsdatum
18 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
178616-2025

Dokumente (2)

Ähnliche Ausschreibungen